Concanavalin-A triggers inflammatory response through JAK/ P40763 signalling and modulates P50281 regulation of P35354 in mesenchymal stromal cells . Pharmacological targeting of inflammation through P40763 and NF-κB signaling pathways is , among other inflammatory biomarkers , associated with cyclooxygenase ( P36551 ) -2 inhibition and is believed to play a crucial role in prevention and therapy of cancer . Recently , inflammatory factors were found to impact on mesenchymal stromal cells ( O60682 ) contribution to tumor angiogenesis . Given O60682 chemotaxis and cell survival are regulated , in part , by the membrane type-1 matrix metalloproteinase ( P50281 ) , an MMP also involved in transducing NF-κB intracellular signaling pathways , we tested whether P40763 regulation by P50281 may also contribute to the expression balance of P35354 in O60682 . We demonstrate that P40763 phosphorylation was triggered in O60682 treated with the P50281 inducer lectin Concanavalin-A ( ConA ) , and that this phosphorylation was abrogated by the O60674 inhibitor AG490 . P50281 gene silencing significantly inhibited ConA-induced P40763 phosphorylation and this was correlated with reduced proMMP-2 activation and P35354 expression . On the other hand , P40763 gene silencing potentiated ConA-induced P35354 expression , providing evidence for a new P50281 /JAK/ P40763 signaling axis that may , in part , explain how P50281 contributes to proinflammatory intracellular signaling . Given that O60682 are avidly recruited within inflammatory microenvironments and within experimental vascularizing tumors , these mechanistic observations support a possible dual control of cell adaptation to inflammation by P50281 and that may enable O60682 to be active participants within inflamed tissues .